Emergence of Colistin-Resistant Acinetobacter junii in China

Zhiren Wang, Xuanyang Fan, Shuyi Wang, Shuguang Li, Yue Gao, Hui Wang, Henan LiAntibiotics 2022 · DOI

TL;DR

This study identifies and characterizes a rare case of colistin-resistant Acinetobacter junii in China. The research points to novel point mutations in key resistance-related genes as the likely cause, suggesting a potential fitness cost associated with this resistance.

What Problem Does This Paper Address?

The rise of multidrug-resistant (MDR) Gram-negative bacteria is a critical global health concern. While Acinetobacter baumannii is a well-known culprit, other Acinetobacter species, like Acinetobacter junii, are increasingly recognized as significant pathogens, particularly in vulnerable patient populations. Colistin is a last-resort antibiotic for treating infections caused by MDR Gram-negative bacteria. However, the emergence of colistin resistance is a growing threat. While colistin resistance in A. baumannii is relatively well-studied, reports of colistin-resistant A. junii are scarce, leaving a knowledge gap regarding its prevalence, mechanisms, and clinical implications. This paper aims to fill this gap by investigating a specific colistin-resistant A. junii isolate.

Methods

The researchers employed a multi-faceted approach:

  • Phenotypic Characterization: This involved observing the colony morphology of the resistant isolate (AJ6079) on agar plates and using transmission electron microscopy (TEM) to examine its cellular structure, particularly the outer membrane. Antibiotic susceptibility testing (broth microdilution assays) was performed to determine the resistance profile against various antibiotics.
  • Genomic Analysis: Whole-genome sequencing was conducted on the resistant isolate (AJ6079) and a comparable colistin-susceptible A. junii isolate (AOR27). Bioinformatic tools were used for genome assembly, annotation, and identification of potential resistance and virulence genes. Comparative genomic analysis, including multiple sequence alignment of key genes, was performed to pinpoint genetic differences.
  • Growth Curve Analysis: To assess the fitness cost associated with colistin resistance, growth curves of the resistant and susceptible isolates were compared under laboratory conditions.

Datasets

  • Clinical Isolates: The study utilized a colistin-resistant Acinetobacter junii isolate (AJ6079) obtained from a patient's blood sample in China. A colistin-susceptible Acinetobacter junii isolate (AOR27) with a similar genetic background was used for comparative analysis.
  • Public Databases: The study referenced and utilized data from public databases such as GenBank (for the deposited genome sequence of AJ6079), VFDB (Virulence Factor Database), and ResFinder for identifying resistance genes.

Key Insights and Ideas

  • Rare Emergence: The identification of a colistin-resistant A. junii isolate is significant given the rarity of such reports, highlighting the potential for resistance to emerge in less commonly studied species.
  • Novel Resistance Mutations: The study identified several previously unreported point mutations in genes known to be involved in colistin resistance (e.g., pmrB, lpxA, lpxD). This suggests that A. junii may develop colistin resistance through distinct genetic alterations compared to A. baumannii.
  • Fitness Cost: The colistin-resistant isolate exhibited a significantly slower growth rate, indicating a potential fitness cost associated with resistance. This could influence the clinical prevalence and spread of such strains.
  • Outer Membrane Thickening: TEM revealed a thicker outer membrane in the resistant isolate, which might contribute to reduced colistin permeability and thus resistance.

Key Results

  • A colistin-resistant Acinetobacter junii isolate (AJ6079) was identified from a bloodstream infection in China.
  • AJ6079 was resistant to colistin (MIC = 4 mg/L) but susceptible to other common antibiotics, including carbapenems, aminoglycosides, quinolones, and tigecycline.
  • Genomic analysis revealed no mobile colistin resistance (mcr) genes or known plasmid-borne resistance genes.
  • Novel amino acid substitutions were identified in pmrB (N5K, G147C), lpxA (I107F, H131Y), and lpxD (F20I, K263R) in the resistant isolate compared to the susceptible one.
  • The colistin-resistant isolate AJ6079 showed a significantly slower growth rate (P < 0.05) compared to the susceptible isolate AOR27.
  • TEM showed AJ6079 possessed a thick outer membrane.

Limitations and Future Work

The authors acknowledge several limitations:

  • Isogenic Relationship: The study used a colistin-susceptible isolate (AOR27) that was not perfectly isogenic with the resistant isolate (AJ6079). This makes it challenging to definitively attribute the observed phenotypic changes solely to the identified mutations. Future work should involve constructing isogenic strains to confirm the causal relationship.
  • Small Sample Size: The study focused on a single isolate, limiting the ability to generalize findings to all colistin-resistant A. junii strains.
  • Heteroresistance: The MIC value for colistin was close to proposed resistance breakpoints, and the possibility of heteroresistance (subpopulations with varying resistance levels) could not be ruled out by the methods used.
  • Proteomic and Functional Studies: Further functional analysis of the identified mutations and proteomic studies are needed to fully elucidate the mechanisms of colistin resistance in A. junii.
  • Epidemiological Data: Collection of more epidemiological data on colistin resistance in A. junii is crucial to understand its prevalence and clinical impact.

The authors suggest that further research should focus on functional validation of the identified mutations, exploring the role of the outer membrane in resistance, and expanding surveillance efforts for colistin-resistant A. junii.

Summary updated

Abstract

The increasing number of multidrug-resistant Gram-negative bacteria presents a serious threat to global health. However, colistin-resistant <i>Acinetobacter junii</i> has rarely been reported. We identified a colistin-resistant <i>A. junii</i> clinical isolate, AJ6079, in blood. The colony of AJ6079 presented a dry phenotype, and it was difficult to form a bacterial suspension, whilst transmission electron microscopy revealed that AJ6079 possessed a thick outer membrane. The phenotypic and genomic comparisons were conducted with one colistin-susceptible <i>A. junii</i>, which had the same antibiotic susceptibility profile except for colistin, and had the same KL25 capsule biosynthesis locus. The AJ6079 exhibited a slower growth rate, indicating that colistin-resistant <i>A. junii</i> possesses a higher fitness cost. The genome of AJ6079 had a G+C content of 38.7% and contained one 3,362,966 bp circular chromosome with no plasmid or mobile colistin resistance (<i>mcr</i>) gene. Comparative genomic analysis revealed that the AJ6079 contained several previously unreported point mutations in colistin-resistance-related genes involving amino acid substitutions in PmrB (N5K, G147C), LpxA (I107F, H131Y), and LpxD (F20I, K263R), which might be correlated with colistin resistance in <i>A. junii</i>. Further research is needed for verification as the genetic background was not exactly the same between the two isolates.
BibTeX
@inproceedings{wang2022emergence,
  author = {Zhiren Wang and Xuanyang Fan and Shuyi Wang and Shuguang Li and Yue Gao and Hui Wang and Henan Li},
  title = {{Emergence of Colistin-Resistant Acinetobacter junii in China}},
  booktitle = {Antibiotics},
  year = {2022},
  doi = {10.3390/antibiotics11121693},
}
Figure